Prevalence of HIV/AIDS among Transgender People in Three Big Cities of Punjab, Pakistan
DOI:
https://doi.org/10.54112/bcsrj.v7i5.2313Keywords:
HIV Infections; Transgender Persons; Cross-Sectional StudiesAbstract
HIV/AIDS remains a major public health concern among transgender populations due to the combined effects of social exclusion, stigma, limited healthcare access, unsafe sexual practices, and poor HIV testing coverage. In Pakistan, city-level evidence on HIV burden among transgender communities is still limited. Objective: To determine the prevalence of HIV/AIDS and assess related sociodemographic, behavioral, awareness, and healthcare-access factors among transgender individuals in Punjab, Pakistan. Methods: This descriptive cross-sectional study included 150 transgender participants from various cities in Punjab, Pakistan, from January 2025 to December 2025. Participants were recruited through healthcare facilities, HIV treatment centers, community outreach activities, and transgender support organizations using a non-probability convenience sampling technique. Data were collected through a structured questionnaire, available medical records, and HIV testing reports. Information was obtained regarding demographic characteristics, HIV awareness, sexual behavior, condom use, sex work, injectable drug use, needle sharing, healthcare access, discrimination, HIV testing history, and HIV test results. Data were analyzed using SPSS version 27. Categorical variables were presented as frequencies and percentages. Associations between HIV test result category and selected variables were assessed using Pearson's chi-square test, with p<0.05 considered statistically significant. Results: Among 150 transgender participants, the highest proportion was in the 35–44-year age group (41; 27.3%), followed by the 25–34-year age group (40; 26.7%). Gender identity included transgender women (41, 27.3%), Khawaja Sira (40, 26.7%), other gender identities (40, 26.7%), and transgender men (29, 19.3%). Overall, 117 (78.0%) participants had heard about HIV/AIDS, but only 46 (30.7%) knew that condom use can prevent HIV transmission. A history of sexual intercourse was reported by 131 (87.3%) participants, 51 (34.0%) had more than five sexual partners in the previous six months, 50 (33.3%) never used condoms, and 62 (41.3%) were involved in sex work. 29 (19.3%) participants reported injectable drug use and needle sharing by 15 (10.0%). Overall, 90 (60.0%) participants had ever been tested for HIV. HIV positivity was 33/150 (22.0%) in the full sample, 33/90 (36.7%) among ever-tested respondents, and 33/65 (50.8%) among those with known positive or negative results. Knowledge of HIV testing services (χ²=14.797, p=0.002), injectable drug use (χ²=12.125, p=0.007), HIV testing status (p<0.001), and time since last HIV test (p<0.001) were significantly associated with HIV test-result category. Conclusion: A considerable burden of HIV/AIDS was observed among transgender participants in Punjab, particularly among those with available HIV test results. Limited condom-related knowledge, inconsistent condom use, multiple sexual partners, sex work, injectable drug use, poor healthcare access, and discrimination indicate the need for transgender-friendly HIV prevention, confidential testing, harm-reduction services, and effective linkage to care.
Downloads
References
1. Stutterheim SE, van Dijk M, Wang H, Jonas KJ. The worldwide burden of HIV in transgender individuals: an updated systematic review and meta-analysis. PLoS One. 2021;16(12). DOI: https://doi.org/10.1371/journal.pone.0260063
2. Moradi G, Soheili M, Bahrami P, Ezzati Amini E, Rashti R, Azadnia A, et al. A systematic review and meta-analysis of HIV/AIDS prevalence among transgender populations worldwide. Health Sci Rep. 2025;8(3). DOI: https://doi.org/10.1002/hsr2.70500
3. Ali Shah S, Qayyum S, Baig S, Iftikhar N, Bukhari RL, Ali W, et al. Results of community-based TB and HIV screening among transgender women and male sex workers in Pakistan. PLOS Glob Public Health. 2023;3(1). DOI: https://doi.org/10.1371/journal.pgph.0000913
4. Shah SA, Zubair M, Soomro A, Sheikh R, Zhamalbekova A, Abidi SH. Analysis of seroprevalence and risk factors for syphilis and HIV among female sex workers and transgender individuals in different cities of Sindh, Pakistan. PLoS One. 2025;20(1). DOI: https://doi.org/10.1371/journal.pone.0312683
5. Bano S, Rahat R, Fischer F. Inconsistent condom use for prevention of HIV/STIs among street-based transgender sex workers in Lahore, Pakistan: socio-ecological analysis based on a qualitative study. BMC Public Health. 2023;23(1):635. DOI: https://doi.org/10.1186/s12889-023-15550-w
6. Manzoor I, Khan ZH, Tariq R, Shahzad R. Health problems and barriers to healthcare services for the transgender community in Lahore, Pakistan. Pak J Med Sci. 2022;38(1):138-144. DOI: https://doi.org/10.12669/pjms.38.1.4375
7. Ahmad HF, Banuri S, Bokhari F. Discrimination in healthcare: a field experiment with Pakistan's transgender community. Labour Econ. 2024;87:102490. DOI: https://doi.org/10.1016/j.labeco.2023.102490
8. Jadoon AH, Shahzad M, Khattak SI, Ali A, Jennings HM, Khattak MI. Experiences of transwomen individuals in accessing oral health care in a low- and middle-income country: a qualitative study from Pakistan. BMC Public Health. 2025;25(1):937. DOI: https://doi.org/10.1186/s12889-025-22073-z
9. Sok S, Hong R, Chhoun P, Chann N, Tuot S, Mun P, et al. HIV risks and recent HIV testing among transgender women in Cambodia: findings from a national survey. PLoS One. 2020;15(9). DOI: https://doi.org/10.1371/journal.pone.0238314
10. Lee K, Trujillo L, Olansky E, Robbins T, Finlayson T, Agnew-Brune C, et al. Factors associated with use of HIV prevention and health care among transgender women—seven urban areas, 2019–2020. MMWR Morb Mortal Wkly Rep. 2022;71(20):673-679. DOI: https://doi.org/10.15585/mmwr.mm7120a1
11. Chiu I, Cano D, Leathers M, Turner CM, Trujillo D, Sicro S, et al. HIV and hepatitis C virus infection and co-infection among trans women in San Francisco, 2020. PLoS One. 2024;19(9). DOI: https://doi.org/10.1371/journal.pone.0307990
12. Reisner SL, Silva-Santisteban A, Apedaile D, Huerta L, Rios I, Aguayo-Romero R, et al. Co-occurring psychosocial conditions are associated with increased HIV acquisition and transmission risk among young transgender women in Lima, Peru. Sci Rep. 2025;15:15577. DOI: https://doi.org/10.1038/s41598-025-99933-6
13. Xia D, Chen Y, Chang R, Xu C, Yu X, Liu Y, et al. Psychosocial problems and condomless anal sex among transgender women in two cities of China: a study based on the syndemic framework. Int J Environ Res Public Health. 2022;19(23):16161. DOI: https://doi.org/10.3390/ijerph192316161
14. Morris E, Teplinskaya A, Olansky E, Rinderle JK, Chapin-Bardales J. Characteristics associated with pre-exposure prophylaxis discussion and use among transgender women without HIV infection—National HIV Behavioral Surveillance Among Transgender Women, seven urban areas, United States, 2019–2020. MMWR Suppl. 2024;73(Suppl 1):9-20. DOI: https://doi.org/10.15585/mmwr.su7301a2
15. Hershow RB, Trujillo L, Olansky E, Lee K, Agnew-Brune C, Wejnert C, et al. Structural and psychosocial syndemic conditions and condomless anal intercourse among transgender women—National HIV Behavioral Surveillance Among Transgender Women, seven urban areas, United States, 2019–2020. MMWR Suppl. 2024;73(Suppl 1):21-33. DOI: https://doi.org/10.15585/mmwr.su7301a3
16. Baugher AR, Olansky E, Sutter L, Cha S, Lewis R, Morris E, et al. Prevalence of discrimination and the association between employment discrimination and health care access and use—National HIV Behavioral Surveillance Among Transgender Women, seven urban areas, United States, 2019–2020. MMWR Suppl. 2024;73(Suppl 1):51-60. DOI: https://doi.org/10.15585/mmwr.su7301a6
17. Goldhammer H, Malina S, Keuroghlian AS. HIV care continuum interventions for transgender women: a topical review. Public Health Rep. 2023;138(1):19-30. DOI: https://doi.org/10.1177/00333549211065517
18. Becasen JS, Denard CL, Mullins MM, Higa DH, Sipe TA. HIV care outcomes among transgender persons with HIV infection in the United States: a systematic review and meta-analysis, 2006–2021. AIDS. 2022;36(2):305-315. DOI: https://doi.org/10.1097/QAD.0000000000003109
19. Jongen VW, Daans C, van Sighem A, Schim van der Loeff M, Hage K, Welling C, et al. Assessing the HIV care continuum among transgender women during 11 years of follow-up: results from the Netherlands’ ATHENA observational cohort. J Int AIDS Soc. 2024;27(8). DOI: https://doi.org/10.1002/jia2.26317
20. Rodriguez A, Horvath KJ, Dowshen N, Voss R, Warus J, Jacobs M, et al. Awareness and utilization of pre-exposure prophylaxis and HIV prevention services among transgender and non-binary adolescent and young adults. Front Reprod Health. 2024;5:1150370. DOI: https://doi.org/10.3389/frph.2023.1150370
21. Moreno-García S, González-Recio P, Donat M, Iniesta C, Folch C, Alonso-Colón M, et al. Inequities in HIV prevention among trans and/or non-binary people: a cross-sectional survey analysis of PrEP and PEP awareness and use in Spain. Int J Equity Health. 2025;24(1):197. DOI: https://doi.org/10.1186/s12939-025-02574-4
22. Hussain A, Rahim A, Rajput F. The quality of life of HIV positive transgender and homosexual population in Karachi, Pakistan. Pak J Med Sci. 2023;39(4):1202-1207. DOI: https://doi.org/10.12669/pjms.39.4.6445
Downloads
Published
How to Cite
License
Copyright (c) 2026 Muhammad Abdul Rehman, Muhammad Bilal, . Abdullah, Muhammad Talaha Shoukat, Muhammad Haseeb Nawaz, Kashif Shabbir, Ans Haider, Mahad Yasin, Muhammad Noman

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.





